Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
Clin Colorectal Cancer
; 15(2): 128-34, 2016 06.
Article
em En
| MEDLINE
| ID: mdl-26385572
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Retais
/
Adenocarcinoma
/
Quimioterapia Adjuvante
/
Terapia Neoadjuvante
/
Quimiorradioterapia Adjuvante
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article